Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
124 participants
INTERVENTIONAL
2009-08-31
2015-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Biotin on Routine Laboratory Values
NCT03995277
Influence of Genetics on Vitamin Metabolism in Pregnant Women
NCT00340366
Determining Total Aromatic Amino Acid Requirements in Pregnant Women
NCT03409939
Methionine Requirements During Healthy Human Pregnancy
NCT04326322
The Absorption of Vitamin B12 Among Healthy Pregnant Women
NCT00730093
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
placebo
biotin
capsule approximately 30 mcg daily 21 days
biotin
biotin
capsule 300 mcg daily 21 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
biotin
capsule approximately 30 mcg daily 21 days
biotin
capsule 300 mcg daily 21 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* in early pregnancy (less than 15 weeks gestation)
* under care of physician
* normal pregnancy
* taking prenatal vitamin with less than 30 mcg biotin
Exclusion Criteria
* antibiotic use
* known renal disease
* drug, alcohol abuse
* gastric bypass
* daily diet high in biotin
* use of certain meal replacement products high in biotin
* previous history of children with birth defects
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Arkansas
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Donald M Mock, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
University of Arkansas
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
107068
Identifier Type: -
Identifier Source: secondary_id
3114301
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.